Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Word on the street at the J.P. Morgan Healthcare Conference 2023

2023年2月1日

作者

点击此处了解更多
公司/并购与资本市场

A Note on Consumption Restrictions and Exit Restrictions

Reflections on the Chinese Legal Environment

2023年5月26日
Briefing

作者 Dr. Jakob Riemenschneider, RA/StB

点击此处了解更多
酒店与休闲

Update on cannabis legalisation: working draft of a cannabis law

2023年5月25日
Briefing

作者 Dr. Daniel Tietjen 以及 Dr. Martin Jäger

点击此处了解更多
环境、社会和公司治理 (ESG)

Greenstone+ becomes part of Cority, expanding Cority’s Sustainability and Environmental solutions

2023年5月22日

作者 Robert Fenner 以及 Paul Thorpe

点击此处了解更多

与我会面: